This increase was consistently observed in patient biopsy samples and online patient databases, with GBM tumour tissue having higher BRG1 expression in comparison to both adjacent normal brain tissue and low-grade glioma [63, 64]. The gene discussed is SMARCA4; the disease is central nervous system cancer.